Incannex Healthcare Limited (IXHL) Key Metrics

NASDAQ: IXHLValuation, returns, debt and efficiency ratios over 2 years.

IXHL valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$35.4M
Enterprise value
−$33.1M
P/E (TTM)
—
Forward P/E
3.8
PEG ratio
—
Price / sales
84.2
Price / book
0.5
EV / EBITDA
—
Dividend yield
—
Beta
2.82

IXHL key metrics, FY2025–FY2026

Fiscal year ended June 30, 2026 · U.S. dollars

IXHL returns How much profit the business earns on the capital it uses.

Return on equity+302.4 pts
−47.8%
FY2026 · hover or tap a bar for each year
FY2025: −350.2%FY2026: −47.8% (+302.4 pts)
FY2025FY2026
Return on assets+188.0 pts
−41.3%
FY2026 · hover or tap a bar for each year
FY2025: −229.3%FY2026: −41.3% (+188.0 pts)
FY2025FY2026
Asset turnover−100.0%
0.00
FY2026 · hover or tap a bar for each year
FY2025: 0.00FY2026: 0.00 (−100.0%)
FY2025FY2026

IXHL valuation history

Fiscal year-endToday2-year median

IXHL returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

IXHL debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

IXHL price vs earnings per share

Share price at year-endEPS (right axis)

IXHL key metrics

FY2025–FY2026
Incannex Healthcare Limited key metrics by fiscal year
FY2026FY2025
Valuation
Market capitalization$43.8M—
Enterprise value−$23.8M—
Price / book0.7—
Earnings yield−44.0%—
Free cash flow yield−29.4%—
Share price at fiscal year-end$3.76$6.48
Per share
Revenue per share$0.00—
Earnings per share−$1.66—
Operating cash flow per share−$1.10—
Free cash flow per share−$1.10—
Cash per share$5.81—
Book value per share$5.78—
Tangible book value per share$5.78—
Capex per share$0.00—
Debt per share$0.01—
Shares outstanding11.7M—
Returns & profitability
Return on equity (ROE)−47.8%−350.2%
Return on assets (ROA)−41.3%−229.3%
Return on tangible assets−26.4%−229.3%
Financial health
Total debt$96,000$258,000
Cash & short-term investments$67.7M$15.0M
Net debt−$67.6M−$14.8M
Debt / equity0.000.02
Debt / assets0.000.01
Current ratio48.812.86
Quick ratio48.812.86
Interest coverage—-78.5
Working capital$71.3M$13.0M
Invested capital−$242,000−$1.4M
Tangible asset value$67.4M$13.4M
Net current asset value$67.2M$12.9M
Graham net-net per share$5.33—
Capital allocation
Capex / revenue—9.3%
Capex / depreciation0.040.03
Stock-based compensation / revenue—3,033.7%
R&D / revenue—12,496.5%
SG&A / revenue—15,265.1%
Efficiency
Days sales outstanding—19,633.6
Days payables outstanding—9,012.2
Cash conversion cycle (days)—10,621.4
Receivables turnover—0.02
Payables turnover—0.04
Asset turnover0.000.00
Average receivables—$4.6M
Average payables—$6.1M
Intangibles / total assets0.0%0.0%

Computed from IXHL's annual financial statements (latest annual report filed September 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

IXHL valuation and financial ratios

Incannex Healthcare earned a return on equity of −47.8% in fiscal 2026. It ended the year with $0.1 million of debt and $67.7 million in cash and short-term investments, a net cash position of $67.6 million.

See the IXHL income statement, the IXHL chart for price history, or the IXHL stock overview for the latest quote and news.

IXHL key metrics FAQ

What is Incannex Healthcare's return on equity?

Incannex Healthcare's return on equity (ROE) was −47.8% in fiscal 2026: net income of -$19.3 million on average shareholders' equity of $40.4 million.

How much debt does Incannex Healthcare have?

Incannex Healthcare had total debt of $0.1 million at the end of fiscal 2026, a debt-to-equity ratio of 0.00 and more cash than debt.

What is Incannex Healthcare's free cash flow yield?

Incannex Healthcare generated -$12.9 million of free cash flow in fiscal 2026, a free cash flow yield of −29.4% on its market value at year-end ($43.8 million).

What is Incannex Healthcare's current ratio?

Incannex Healthcare's current ratio was 48.81 at the end of fiscal 2026: current assets were 48.81 times current liabilities.

Drug Manufacturers - Specialty & Generic key metrics